Filing Details

Accession Number:
0000711377-11-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-05 13:00:00
Reporting Period:
2011-04-01
Filing Date:
2011-04-05
Accepted Time:
2011-04-05 16:13:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-01 26,000 $13.55 851,424 No 4 M Direct
Common Stock Disposition 2011-04-01 26,000 $41.13 825,424 No 4 S Direct
Common Stock Acquisiton 2011-04-01 2,109 $19.55 827,533 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to buy) Disposition 2011-04-01 26,000 $0.00 26,000 $13.55
Common Stock Common Stock Option (Right to buy) Disposition 2011-04-01 4,001 $19.55 4,001 $19.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,818 2012-08-09 No 4 M Direct
54,817 2014-08-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 194,320 Indirect See Footnotes
Footnotes
  1. The option plan provides for the exchange of outstanding options for currently valued shares in an amount equal to the employee's equity in the options held.
  2. The shares are held in trust for the benefit of Judith Herbert, spouse of James Herbert.
  3. The options were graqnted 8/9/2007 and became exercisable 20% yearly thereafter.
  4. The options were granted 8/24/2009 and became exercisable 20% yearly thereafter